Search hospitals > Massachusetts > Worcester
University of Massachusetts Memorial Medical Center
Claim this profileWorcester, Massachusetts 01605
Global Leader in Ovarian Cancer
Global Leader in Cancer
Conducts research for Leukemia
Conducts research for Adenocarcinoma
Conducts research for Peritoneal Cancer
350 reported clinical trials
32 medical researchers
Summary
University of Massachusetts Memorial Medical Center is a medical facility located in Worcester, Massachusetts. This center is recognized for care of Ovarian Cancer, Cancer, Leukemia, Adenocarcinoma, Peritoneal Cancer and other specialties. University of Massachusetts Memorial Medical Center is involved with conducting 350 clinical trials across 411 conditions. There are 32 research doctors associated with this hospital, such as Ajit Puri, MD, Susan Zweizig, MD, Vaikom Mahadevan, MD, and Jonathan Gerber.Area of expertise
1Ovarian Cancer
Global LeaderStage III
Stage IV
Stage II
2Cancer
Global LeaderStage III
Stage IV
Stage II
Top PIs
Ajit Puri, MDUniversity of Massachusetts3 years of reported clinical research
Studies Stroke
Studies Ischemic Stroke
12 reported clinical trials
22 drugs studied
Susan Zweizig, MDUniversity of Massachusetts4 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
11 reported clinical trials
22 drugs studied
Vaikom Mahadevan, MDUniversity of California at San Francisco6 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Heart Valve Disease
7 reported clinical trials
8 drugs studied
Jonathan GerberUMass Memorial Medical Center1 year of reported clinical research
Studies Syndrome
Studies Myelodysplastic Syndrome
6 reported clinical trials
17 drugs studied
Clinical Trials running at University of Massachusetts Memorial Medical Center
Multiple Sclerosis
Stroke
Bladder Cancer
Duchenne Muscular Dystrophy
Lymphoma
Non-Hodgkin's Lymphoma
B-Cell Lymphoma
Ovarian Cancer
Fallopian Tube Cancer
Muscular Dystrophy
Ocrelizumab
for Multiple Sclerosis
This trial is testing if patients with early relapsing multiple sclerosis can stop taking Ocrelizumab after initial treatment without their disease getting worse. Ocrelizumab is a medication given through an IV that helps manage multiple sclerosis by reducing harmful immune cells. The study will monitor patients for new disease activity over several years.
Recruiting2 awards Phase 4
Stem Cell Transplant vs Best Available Therapy
for Multiple Sclerosis
This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) to the treatment strategy of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized at a 1 to 1 (1:1) ratio. All participants will be followed for 72 months after randomization (Day 0, Visit 0).
Recruiting2 awards Phase 312 criteria
IMS001
for Multiple Sclerosis
This trial tests IMS001, a treatment made from special cells, on Multiple Sclerosis patients who haven't had success with other treatments. These cells might help control or slow down the disease.
Recruiting1 award Phase 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Massachusetts Memorial Medical Center?
University of Massachusetts Memorial Medical Center is a medical facility located in Worcester, Massachusetts. This center is recognized for care of Ovarian Cancer, Cancer, Leukemia, Adenocarcinoma, Peritoneal Cancer and other specialties. University of Massachusetts Memorial Medical Center is involved with conducting 350 clinical trials across 411 conditions. There are 32 research doctors associated with this hospital, such as Ajit Puri, MD, Susan Zweizig, MD, Vaikom Mahadevan, MD, and Jonathan Gerber.
Where is University of Massachusetts Memorial Medical Center located?
The University of Massachusetts Memorial Medical Center is situated at 55 N Lake Ave, Worcester, MA 01655. For directions, take the Mass. Turnpike West to Exit 10, then I-290 East to Exit 21, turn right onto Plantation Street, and continue to the third traffic light to find the campus on the left. Alternatively, consider using Waze for real-time driving directions.
Who should I call to ask about financial aid or insurance network?
For financial assistance at University of Massachusetts Memorial Medical Center, contact the Patient Financial Counseling Department at UMass Memorial Health. For insurance inquiries, including questions, enrollments, waivers, and verification, reach out to the Patient Services/Student Health Benefit Plan (SHBP) office at (413) 577-5192 or patientservices@uhs.umass.edu. For billing questions, contact the Patient Accounts/Billing office at (413) 577-5256.
What insurance does University of Massachusetts Memorial Medical Center accept?
The University of Massachusetts Memorial Medical Center accepts a variety of insurance plans, including commercial plans such as Commonwealth Care Alliance, MultiPlan Network, and Veterans Administration Community Care network VA CCN. Managed Medicaid plans include Fallon 365 ACO and Mass General Brigham ACO, while Medicare Advantage plan participation is limited to select products/providers. The hospital also participates with Original Medicare and offers 10 health plans for staff, including Unicare State Indemnity Plan and Harvard Pilgrim Independence Plan.
What awards or recognition has University of Massachusetts Memorial Medical Center received?
The University of Massachusetts Memorial Medical Center in Worcester, Massachusetts, is renowned for its exceptional staff and groundbreaking contributions to medical research. Highlights include Dr. David Lyons being named "Best Cardiologist" at the Best of Central MA Awards Gala, the Cancer Research Office receiving accolades for its performance from the Eastern Cooperative Oncology Group, and the Hospital at Home team being recognized as "Program of the Year" by the National Association of Home Care & Hospice. Additionally, its affiliated UMass Chan Medical School secures over $300 million annually in research funding, supporting significant studies in areas like Argonaute syndromes and COVID-19 rapid tests.